Cargando…
Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209969/ https://www.ncbi.nlm.nih.gov/pubmed/32384906 http://dx.doi.org/10.1186/s13054-020-02934-2 |
| _version_ | 1783531188725481472 |
|---|---|
| author | Pantos, Constantinos Tseti, Ioulia Mourouzis, Iordanis |
| author_facet | Pantos, Constantinos Tseti, Ioulia Mourouzis, Iordanis |
| author_sort | Pantos, Constantinos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7209969 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72099692020-05-11 Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial Pantos, Constantinos Tseti, Ioulia Mourouzis, Iordanis Crit Care Research Letter BioMed Central 2020-05-08 /pmc/articles/PMC7209969/ /pubmed/32384906 http://dx.doi.org/10.1186/s13054-020-02934-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Research Letter Pantos, Constantinos Tseti, Ioulia Mourouzis, Iordanis Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial |
| title | Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial |
| title_full | Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial |
| title_fullStr | Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial |
| title_full_unstemmed | Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial |
| title_short | Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial |
| title_sort | use of triiodothyronine to treat critically ill covid-19 patients: a new clinical trial |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209969/ https://www.ncbi.nlm.nih.gov/pubmed/32384906 http://dx.doi.org/10.1186/s13054-020-02934-2 |
| work_keys_str_mv | AT pantosconstantinos useoftriiodothyroninetotreatcriticallyillcovid19patientsanewclinicaltrial AT tsetiioulia useoftriiodothyroninetotreatcriticallyillcovid19patientsanewclinicaltrial AT mourouzisiordanis useoftriiodothyroninetotreatcriticallyillcovid19patientsanewclinicaltrial |